Expansion opportunities Target federal and government healthcare networks leveraging the LIBERTY Endovascular Robotic System through the Lovell Government Services partnership to drive adoption across federal facilities and programs.

Strategic partnerships Leverage the LOA with Sanmina to identify contract manufacturing and scale opportunities, stressing reliability and production capacity to large hospital systems and integrators seeking robotic endovascular solutions.

Clinical validation Capitalize on recent awards and industry recognition to support value stories with surgeons and procurement, emphasizing innovation leadership and safety benefits to drive trial expansions and reimbursement discussions.

Market visibility Attend and showcase at robotic surgery and digital surgery events to generate brand awareness, generate leads among hospital groups and vascular centers, and accelerate pilot programs for LIBERTY system adoption.

Financial readiness Position as a growing revenue focused innovator with a clear path to profitability, aligning with capital budget cycles and potential equipment financing partners to accelerate procurement by large care networks.